Recent

% | $
Quotes you view appear here for quick access.

Qihoo 360 Technology Co. Ltd. Message Board

shipleych 20 posts  |  Last Activity: Dec 17, 2015 8:11 PM Member since: Dec 7, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • shipleych by shipleych Dec 17, 2015 8:11 PM Flag

    Added 6k More Ibio shares to my Ibio stock pile.. this stock will start flying very soon - to much good news right around the corner!!

    Sentiment: Strong Buy

  • Reply to

    my order did not fill

    by iamrichurdumb Sep 18, 2015 5:30 PM
    shipleych shipleych Sep 19, 2015 3:52 PM Flag

    best of luck on you order.. what are you going to do if it doesn't fill next week?

  • Reply to

    ZMAPP gets FDA Fastrack???

    by shipleych Sep 18, 2015 4:52 PM
    shipleych shipleych Sep 19, 2015 12:10 PM Flag

    This is from Oct of 2014 This brings us to Ibio Inc. (NYSEMKT:IBIO). According to the New York Times, Federal officials are planning to sharply increase the production of ZMapp, the experimental ebola drug that "cured" US citizens in Africa recently. "The Department of Health and Human Services is in advanced discussions to enlistCaliber Biotherapeutics, a Texas company that can produce the drug in millions of tobacco plants, according to federal officials and pharmaceutical industry executives."

    While researching privately held Caliber I discovered that IBIO has a 2013 partnership with them. Intrigued by the possibilities I spoke to Robert Erwin, President of Ibio to get his take on my research. The findings will astonish you!

    1. Would you comment on IBIO Inc's relationship with Caliber Biotherapeutics?

    "iBio and Caliber announced a License and Collaboration Agreement on February 19, 2013. That Agreement is ongoing."

    2. Does Caliber's plant-based vaccine process use/require Ibio technology? If so does Ibio receive payments/royalties on the use of this technology?

    "The agreement provides for iBio to receive license and milestone fees for development of product targets selected by Caliber and royalties on products sales and other revenues. Detailed financial terms have not been disclosed have not been disclosed."

    3. If Caliber wins the Ebola contract would Ibio be in a position to confirm its use in a press release?

    "Technology used to produce the ZMapp antibodies in plants is covered by issued U.S. patents owned by iBio, and iBio also has additional proprietary technology that can be applied to increase the antibody yields over current levels. However, we cannot speculate on contracts that might or might not be awarded."

    Sentiment: Strong Buy

  • Reply to

    ZMAPP gets FDA Fastrack???

    by shipleych Sep 18, 2015 4:52 PM
    shipleych shipleych Sep 19, 2015 11:44 AM Flag

    I do believe something is in place... Put it this way.. nothing went away... Perhaps we can get some information on this contract. anyone else??

  • Experimental Ebola drug ZMapp gets fast track status from FDA..
    IBIO might be involved for MASS PRODUCTION

    Sentiment: Strong Buy

  • Major Hedge funds too. This thing is going to skyrocket very shortly....
    Cheap price to set yourself up for the future.. buy now and HOLD!!!

    Sentiment: Strong Buy

  • Reply to

    ITS FRIDAY

    by shipleych Aug 28, 2015 12:47 AM
    shipleych shipleych Aug 31, 2015 5:49 PM Flag

    You have no shares... why are you here? wait...I'm sorry you have 1000 shares at .60... ok... I am a liar...

  • Reply to

    ITS FRIDAY

    by shipleych Aug 28, 2015 12:47 AM
    shipleych shipleych Aug 31, 2015 5:48 PM Flag

    You don't even own any shares of this company... why are you here?

  • Reply to

    ITS FRIDAY

    by shipleych Aug 28, 2015 12:47 AM
    shipleych shipleych Aug 28, 2015 11:10 AM Flag

    You don't even own any shares of this company... why are you here?

  • shipleych by shipleych Aug 28, 2015 12:47 AM Flag

    The value of saving many lives who would otherwise be lost during the prolonged period of traditional vaccine and drug development is immeasurable. The flu vaccine market alone is as of 2011 a $2.9 billion market and projected to be $3.8 billion by 2018. Based on my research, I believe the vaccine market is one of the most promising targets for iBio to address global need. Their ability to produce a quicker product would allow them to gain market share very quickly if they can produce an efficacious vaccine. Therefore in the next few years or even during the next pandemic with a higher case count the valuation of iBio whether believed justified or not can easily reach at least $1 billion and therefore make the share price just north of $14 per share. This is obviously a conservative number that does not take into account future advancements in their work with Fiocruz, their IPF drug target, or oncology pipeline.

    Sentiment: Strong Buy

  • shipleych by shipleych Aug 19, 2015 7:25 PM Flag

    http://medicalxpress.com/news/2015-08-usda-production-bird-flu-vaccine.html

    Sentiment: Strong Buy

  • 00:08 EDT 19th August 2015 | BioPortfolio
    Home » Channels » iBioLaunch - Biotech, Pharma and Life Science Channel
    The iBioLaunch™ platform is a proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins. The plants are easily and reliably scaled-up in low cost, controlled growth facilities to produce large amounts of recombinant protein in the plant biomass. The technology is highly flexible having the capability to produce both biotherapeutics and vaccines. Advantages of the whole plant approach include lower operating and capital expenses compared to protein production using engineered microbial or animal cells in bioreactors. The iBioLaunch platform offers significant advantages over earlier plant-based methods that rely on transgenic plants or plant cell cultures. These include the speed at which different proteins can be expressed and produced at commercial scale, which presents a significant commercial advantage, as well as public safety benefits when vaccines for pandemic diseases are required. Other advantages include scalability, no risks of contamination by animal pathogens, and the ability to express complex proteins at which other systems have failed.

    The iBioLaunch technology platform addresses several multi-billion dollar markets. Its applicability to a broad range of product classes enables iBio to target global commercial collaborations in high-growth markets such as orphan biologics ($54.6 billion in 2009), biosimilars/bio-betters (~$80 billion worth of biologics sales will be susceptible to biosimilar competition, by 2013) and new proprietary biologics. The speed and superior economic scalability of the iBioLaunch™ technology make it the ideal platform for new personalized therapeutics as well as for vaccines ($32 billion in 2013).

    Sentiment: Strong Buy

  • shipleych by shipleych Aug 4, 2015 9:06 AM Flag

    ADDING MORE good reports coming!!

    Sentiment: Strong Buy

  • Reply to

    JD will be back over $35 soon...

    by placesontherun37 Jul 14, 2015 8:23 PM
    shipleych shipleych Jul 17, 2015 5:00 PM Flag

    Before you know it, this stock will be trading in the 100's. This company is way to big and successful. They haven't even declared a profit yet, but they will and when they do it will head only north... GL to all Longs!!

    Sentiment: Strong Buy

  • Reply to

    Watch for possible breakout

    by wlenaty Jul 13, 2015 11:25 AM
    shipleych shipleych Jul 13, 2015 10:32 PM Flag

    wlenaty, I could not agree any more with you... jd is going up.. I think it will be 40 plus sometime in August... this thing will blast through its old high of 38... GL..

    Sentiment: Strong Buy

  • Reply to

    when?

    by starteam00003 Jul 9, 2015 10:17 PM
    shipleych shipleych Jul 9, 2015 11:58 PM Flag

    thought you sold all of your stash?

  • Reply to

    Good News Underway

    by shipleych Jul 8, 2015 9:20 PM
    shipleych shipleych Jul 9, 2015 9:14 PM Flag

    Al - Please. come on... you know about the trials (right??) and the trials are completing this month.. or I should say (July 2015). There are 3 drugs in 1 phase.. IBIO is going to post "News" this month like they do almost every month.. All the bits and pieces of IBIO information on these trials all I see is positive news... I haven't seen anything negative yet except competition. Let me see if I can find some of the positive news and post it... Nelson- Correction: if we get 1/3 this stock can hit $5.00 and 2/3 it can hit $10.00

    Sentiment: Strong Buy

  • shipleych by shipleych Jul 8, 2015 9:20 PM Flag

    IBIO shouldn't move much lower. Good News is coming this month for 3 of their trials and results thus far have been very promising. strap in your seat belt, sit back and get ready to move forward... GO LONGS...
    Get in and get ready!!!!!!

    Sentiment: Strong Buy

  • Reply to

    JD to OVER 40.....

    by shipleych Jun 30, 2015 5:32 PM
    shipleych shipleych Jun 30, 2015 9:39 PM Flag

    This is the way it works with every stock on the stockmarket. It gets pumped and dumped but over time it will continue to rise. If you haven't witnessed this before with a stock then watch JD closely... This is one stock you will see this with... Long and Strong... this thing will be in the 100's before you know it....

    Sentiment: Strong Buy

  • shipleych by shipleych Jun 30, 2015 5:32 PM Flag

    Sorry shorts - I understand your pain but this stock is headed North Bound.....This will all happen in the month of JULY Best of luck and enjoy the ride over 40 as well!

    Sentiment: Strong Buy

QIHU
75.27+0.01(+0.01%)Jun 24 4:02 PMEDT